The US Food and Drug Administration issued an updated letter to healthcare providers to disclose interim results from a post-approval study (PAS) of Abiomed Impella RP heart pump system. "These latest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback